Skip to Main Content

WASHINGTON — President Biden’s “moonshot” biomedical research agency will be housed within the National Institutes of Health, according to two sources familiar with the decision-making process.

The decision marks the end of a lengthy debate in Washington about whether the new agency, known as ARPA-H, should be independent or exist as a wing of the NIH.


But there’s a twist: Instead of reporting to the NIH director, the new agency’s leader will report directly to the secretary of health and human services.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.